Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Jan 16, 2026, 4:00 PM EST
1.050
+0.020 (1.94%)
After-hours: Jan 16, 2026, 7:58 PM EST
Senti Biosciences Market Cap
Senti Biosciences has a market cap or net worth of $27.08 million as of January 16, 2026. Its market cap has increased by 68.13% in one year.
Market Cap
27.08M
Enterprise Value
44.42M
1-Year Change
68.13%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since May 26, 2021, Senti Biosciences's market cap has decreased from $256.04M to $27.08M, a decrease of -89.42%. That is a compound annual growth rate of -38.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 27.08M | -0.96% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | 256.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |